Advanced Biotherapy Issues Stockholders Newsletter

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Nov. 29, 2005--Advanced Biotherapy, Inc. (OTCBB:ADVB), dedicated to pioneering the development and use of therapeutic antibodies, today provided the following as an excerpt from the newsletter issued to its stockholders, dated November 15, 2005. The entire text can be reviewed in the Company’s Form 8-K filing with the Securities and Exchange Commission on November 29, 2005.

MORE ON THIS TOPIC